David Rosenbaum - Jan 5, 2023 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/6/2023, 03:29 PM
Previous filing
Nov 23, 2022
Next filing
Feb 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Award $0 +78K +25.91% $0.00 379K Jan 5, 2023 Direct F1
transaction ARDX Common Stock Award $0 +25.3K +28.49% $0.00 114K Jan 5, 2023 By Wife F1, F2
holding ARDX Common Stock 77.6K Jan 5, 2023 Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Award $0 +351K $0.00 351K Jan 5, 2023 Common Stock 351K $2.73 Direct F4
transaction ARDX Stock Option (Right to Buy) Award $0 +116K $0.00 116K Jan 5, 2023 Common Stock 116K $2.73 By Wife F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
F2 The shares are directly held by the Reporting Person's wife.
F3 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
F4 The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.